A phase I/II multi-center study of Troxatyl™ in patients with refractory chronic lymphocytic leukemia (CLL), lymphoma or multiple myeloma (MM).

被引：0
|
作者：
Giles, F
Belanger, R
Toor, A
McLaughlin, P
Fayad, L
Beran, M
Albitar, M
Vose, J
机构：
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Hop Maison Neuve Rosemont, Res Ctr, Montreal, PQ H1T 2M4, Canada
[3] Univ Arkansas Med Sci, Myeloma & Transplantat Ctr, Little Rock, AR 72205 USA
[4] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[5] Univ Nebraska, Med Ctr, Lincoln, NE 68583 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4902
引用
收藏
页码：289B / 289B
页数：1
相关论文
共 50 条
  • [31] Systemic and mucosal immunoglobulin (Ig) levels and risk of infection patients (pts) with chronic lymphocytic leukemia (cll) and multiple myeloma (MM).
    Morrison, VA
    Hibbs, JR
    Janoff, EN
    BLOOD, 1996, 88 (10) : 948 - 948
  • [32] Phase II trial of menogaril in patients with previously treated multiple myeloma or chronic lymphocytic leukemia
    Kucuk, O
    Kilton, L
    Wade, JL
    Blough, R
    Benson, AB
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2000, 23 (04): : 379 - 383
  • [33] Treatment of relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma with everolimus (RAD001) and alemtuzumab: a Phase I/II study
    Zent, Clive S.
    Bowen, Deborah A.
    Conte, Michael J.
    LaPlant, Betsy R.
    Call, Timothy G.
    LEUKEMIA & LYMPHOMA, 2016, 57 (07) : 1585 - 1591
  • [34] Phase II, Single Center Study of Oral Forodesine in Patients with Advanced, Fludarabine-Treated Chronic Lymphocytic Leukemia (CLL)
    Verma, Dushyant
    Balakrishnan, Kumudha
    O'Brien, Susan
    Thomas, Deborah A.
    Ferrajoli, Alessandra
    Wierda, William G.
    Verma, Amit
    Faderl, Stefan
    Bickel, Susan M.
    Bantia, Shanta
    Kantarjian, Hagop M.
    Keating, Michael J.
    Gandhi, Varsha
    Ravandi, Farhad
    BLOOD, 2009, 114 (22) : 935 - 936
  • [35] Exome Sequencing in Chronic Lymphocytic Leukemia (CLL) and Multiple Myeloma (MM) Families Identifies Cosegregating Functional Variants
    Beiggi, Sara
    O'Brien, Daniel R.
    Achenbach, Sara J.
    Rabe, Kari G.
    Call, Timothy G.
    Kay, Neil E.
    Shanafelt, Tait D.
    Norman, Aaron D.
    Cunningham, Julie M.
    Rajkumar, Vincent
    Kumar, Shaji
    Cerhan, James R.
    Vachon, Celine M.
    Slager, Susan L.
    BLOOD, 2014, 124 (21)
  • [36] A phase II multi-center trial of pentostatin plus cyclophosphamide with ofatumumab in older previously untreated chronic lymphocytic leukemia patients
    Tedeschi, Alessandra
    Rossi, Davide
    Motta, Marina
    Quaresmini, Giulia
    Rossi, Marianna
    Coscia, Marta
    Anastasia, Antonella
    Rossini, Fausto
    Cortelezzi, Agostino
    Nador, Guido
    Scarfo, Lydia
    Cairoli, Roberto
    Frustaci, Anna Maria
    Dalceggio, Daniela
    Picardi, Paola
    De Paoli, Lorenzo
    Orlandi, Ester
    Rambaldi, Alessandro
    Massaia, Massimo
    Gaidano, Gianluca
    Montillo, Marco
    HAEMATOLOGICA, 2015, 100 (12) : E501 - E504
  • [37] A Phase II Study of Curcumin and Vitamin D in Previously Untreated Patients with Early Stage Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
    William, Basem M.
    Brillhart, Kaylee
    Afable, Manuel
    Bakalarz, Kristen
    Cooper, Brenda
    Lazarus, Hillard M.
    Gerson, Stanton L.
    Creger, Richard
    Nagabhushanam, Kalyanam
    Grote, James
    Fu, Pingfu
    Kunati, Sandeep
    Yang, Shuming
    Xu, Yan
    Woost, Philip
    Jacobberger, James
    de Lima, Marcos
    Caimi, Paolo
    BLOOD, 2018, 132
  • [38] Phase II Study of Dasatinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Amrein, Philip C.
    Attar, Eyal C.
    Takvorian, Tak
    Hochberg, Ephraim P.
    Ballen, Karen K.
    Leahy, Kathleen M.
    Fisher, David C.
    LaCasce, Ann S.
    Jacobsen, Eric D.
    Armand, Philippe
    Hasserjian, Robert P.
    Werner, Lillian
    Neuberg, Donna
    Brown, Jennifer R.
    CLINICAL CANCER RESEARCH, 2011, 17 (09) : 2977 - 2986
  • [39] Phase I/II Study of Panobinostat and Carfilzomib in Patients (pts) with Relapsed or Refractory Multiple Myeloma (MM), Interim Phase I Safety Analysis
    Berdeja, Jesus G.
    Hart, Lowell
    Lamar, Ruth
    Murphy, Patrick
    Morgan, Susan
    Flinn, Ian W.
    BLOOD, 2012, 120 (21)
  • [40] Preliminary Results From a Phase I/II Study of Fludarabine, Rituximab, and Lenalidomide In Untreated Patients with Chronic Lymphocytic Leukemia (CLL)
    Flinn, Ian W.
    Berdeja, Jesus G.
    Waselenko, Jamie K.
    Cooper, R. Seth
    Bi, Jia
    Shih, Kent
    Doss, Habib H.
    Dickson, Natalie
    Thompson, Dana S.
    Burris, Howard A., III
    Hainsworth, John D.
    BLOOD, 2010, 116 (21) : 1022 - 1022
12345